Barry S. Ticho
2023
In 2023, Barry S. Ticho earned a total compensation of $1.6M as Chief Medical Officer at Stoke Therapeutics, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $177,934 |
|---|---|
| Option Awards | $474,186 |
| Salary | $494,259 |
| Stock Awards | $489,272 |
| Other | $12,356 |
| Total | $1,648,007 |
Ticho received $494.3K in salary, accounting for 30% of the total pay in 2023.
Ticho also received $177.9K in non-equity incentive plan, $474.2K in option awards, $489.3K in stock awards and $12.4K in other compensation.
Rankings
In 2023, Barry S. Ticho's compensation ranked 648th out of 2,338 executives tracked by ExecPay. In other words, Ticho earned more than 72.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 648 out of 2,338 | 72nd |
Division Manufacturing | 363 out of 1,259 | 71st |
Major group Chemicals And Allied Products | 249 out of 711 | 65th |
Industry group Drugs | 244 out of 682 | 64th |
Industry Pharmaceutical Preparations | 159 out of 493 | 68th |
Source: SEC filing on April 23, 2024.
Ticho's colleagues
We found two more compensation records of executives who worked with Barry S. Ticho at Stoke Therapeutics in 2023.